LASTACAFT (Allergan, Inc.)
Welcome to the PulseAid listing for the LASTACAFT drug offered from Allergan, Inc.. This Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Allergan, Inc. |
| NON-PROPRIETARY NAME: | alcaftadine |
| SUBSTANCE NAME: | ALCAFTADINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC] |
| ROUTE: | OPHTHALMIC |
| DOSAGE FORM: | SOLUTION/ DROPS |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2010-11-01 |
| END MARKETING DATE: | 0000-00-00 |
LASTACAFT HUMAN PRESCRIPTION DRUG Details:
| Item Description | LASTACAFT from Allergan, Inc. |
| LABELER NAME: | Allergan, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2.5(mg/mL) |
| START MARKETING DATE: | 2010-11-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0023-4290_048d073a-4490-4c4f-a867-099ab0f7b339 |
| PRODUCT NDC: | 0023-4290 |
| APPLICATION NUMBER: | NDA022134 |
Other ALCAFTADINE Pharmaceutical Manufacturers / Labelers:
